Observational studyAdvances in therapy2023

Evaluation of Patient-Reported Outcomes in Patients with Relapsing Multiple Sclerosis Treated with Cladribine Tablets in the CLAWIR Study: 12-Month Interim Analysis.

Daniela Rau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.